Lectenz Bio in News and Media

8 days ago 0 0

The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further...

23 days ago 0 0

We are excited to have our SiaFind™ products used in the Derda lab at the University of Alberta. Read the paper, “Chemoenzymatic...

July 21, 2023 0 0

The National Institute of Health (NIH) Office of Research Infrastructure Programs (ORIP) awards Lectenz Bio an SBIR Fast-Track to develop N-glycan...

March 31, 2023 0 0

Lectenz Bio has recently signed a distribution agreement with ZAGENO, a European life science distributor. This agreement will allow ZAGENO to...

January 11, 2023 0 0

Lectenz Bio’s paper, “Simplifying the detection and monitoring of protein glycosylation during in vitro glycoengineering,” has...

December 1, 2022 0 0

Cedarlane is now distributing Lectenz Bio products for Canadian customers. We are excited to have Cedarlane listing our catalog and look forward...

November 1, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with MBL Beijing Biotech Co., Ltd., a Chinese life science distributor. This agreement...

June 9, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with Scientist.com, a U.S. life science distributor. This agreement will allow...

May 4, 2022 0 0

Lectenz Bio was excited to have CEO Lori Yang and VP of R&D Sean Wu present at the Common Fund GlycoScience Program!

February 28, 2022 0 0

Lectenz Bio was proud to be a sponsor of the 2022 Rare Disease Day Symposium & CDG/NGLY1 Family Conference! It’s always exciting to see...

February 4, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with Krishgen Biosystems, an Indian life science distributor. This agreement will allow...

December 6, 2021 0 0

Lectenz Bio has recently signed a distribution agreement with Advion Interchim, a French life science distributor. This agreement will allow...